Articles

1. Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroids

   • Jonathan I. Silverberg
   • April Armstrong
   • Kristian Reich

   Review Article Open access 11 September 2023 Pages: 913 - 925

   

2. Correction to: Authors’ Reply to Chen and Chen: Comment on: “Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”

   • Chia-Ling Yu
   • Po-Yi Chou
   • Ching-Chi Chi

   Correction 09 September 2023 Pages: 1003 - 1003

3. Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials

   • Eric L. Simpson
   • Andrew E. Pink
   • Andreas Wollenberg

   Original Research Article Open access 08 September 2023 Pages: 939 - 952

   

4. Relationship of Histopathologic Parameters and Gene Expression Profiling in Malignant Melanoma

   • Alexis G. Strahan
   • Ivan Švagelj
   • Drazen Jukic

   Original Research Article 04 September 2023 Pages: 119 - 126

   

5. Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2

   • Gil Yosipovitch
   • Melinda J. Gooderham
   • Daniela E. Myers

   Original Research Article Open access 25 August 2023 Pages: 127 - 138

   

6. Alopecia Areata: Current Treatments and New Directions

   • Dante Dahabreh
   • Seungyeon Jung
   • Emma Guttman-Yassky

   Review Article 22 August 2023 Pages: 895 - 912

   

7. The 25th World Congress of Dermatology, Singapore, 3–8 July, 2023: Research Highlights

   • Kathy A. Fraser

   Meeting Report 21 August 2023 Pages: 849 - 851

8. Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation

   • Andrea Chiricozzi
   • Michela Ortoncelli
   • Ketty Peris

   Correction Open access 19 August 2023 Pages: 963 - 964

9. Antifungal Resistance, Susceptibility Testing and Treatment of Recalcitrant Dermatophytosis Caused by Trichophyton indotineae: A North American Perspective on Management

   • Aditya K. Gupta
   • Shruthi Polla Ravi
   • Wayne L. Bakotic

   Review Article 08 August 2023 Pages: 927 - 938

   

10. Comorbid Conditions Associated with Alopecia Areata: A Systematic Review and Meta-analysis

    • Sophia Ly
    • Priya Manjaly
    • Arash Mostaghimi

    Systematic Review 18 July 2023 Pages: 875 - 893

    

11. Diagnosis and Management of Dermatologic Adverse Events from Systemic Melanoma Therapies

    • Christopher J. Fay
    • Samantha Jakuboski
    • Nicole R. LeBoeuf

    Review Article 03 July 2023 Pages: 765 - 785

    

12. Characteristics and Burdens of Disease in Patients from Beijing with Generalized Pustular Psoriasis and Palmoplantar Pustulosis: Multicenter Retrospective Cohort Study Using a Regional Database

    • Hai-Meng Wang
    • Jia-Ming Xu
    • Hong-Zhong Jin

    Original Research Article 29 June 2023 Pages: 991 - 1002

    

13. Disease Burden and Treatment Patterns Among US Patients with Hidradenitis Suppurativa: A Retrospective Cohort Study

    • Amit Garg
    • Yvonne Geissbühler
    • Alexa B. Kimball

    Original Research Article Open access 28 June 2023 Pages: 977 - 990

    

14. Authors’ Reply to Chen and Chen: Comment on: “Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”

    • Chia-Ling Yu
    • Po-Yi Chou
    • Ching-Chi Chi

    Letter to the Editor 27 June 2023 Pages: 855 - 858

    

15. Comment on: “Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”

    • Shurong Chen
    • Yi Chen

    Letter to the Editor 27 June 2023 Pages: 853 - 854

16. Dupilumab-Associated Arthritis: A Dermatology-Rheumatology Perspective

    • Michael J. Woodbury
    • Jeffrey S. Smith
    • Joseph F. Merola

    Current Opinion 22 June 2023 Pages: 859 - 864

    

17. Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials

    • Michael Sticherling
    • Arjen F. Nikkels
    • Deborah Keefe

    Original Research Article Open access 21 June 2023 Pages: 821 - 835

18. Do Biologic Treatments for Psoriasis Lower the Risk of Psoriatic Arthritis? A Systematic Review

    • Anna Aronovich
    • Ilya Novikov
    • Lev Pavlovsky

    Systematic Review 21 June 2023 Pages: 865 - 873

    

19. Climate Change, Skin Health, and Dermatologic Disease: A Guide for the Dermatologist

    • Annika Belzer
    • Eva Rawlings Parker

    Review Article 20 June 2023 Pages: 577 - 593

    

20. Commentary on “Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology”

    • Heli Patel
    • Steven R. Feldman

    Commentary 20 June 2023 Pages: 497 - 498

21. Atopic Dermatitis Across Shades of Skin

    • Victor L. Quan
    • Taylor Erickson
    • Raj Chovatiya

    Review Article 19 June 2023 Pages: 731 - 751

    

22. Baricitinib: A Review in Severe Alopecia Areata

    • Simon Fung
    • Matt Shirley

    Adis Drug Evaluation 16 June 2023 Pages: 661 - 668

    

23. Targeting Inflammation in Acne: Current Treatments and Future Prospects

    • Sebastian Cruz
    • Natalia Vecerek
    • Nada Elbuluk

    Leading Article Open access 16 June 2023 Pages: 681 - 694

24. Capturing the Diversity of Dermatology—What’s in a Name?

    • Taylor Erickson
    • Karishma Daftary
    • Raj Chovatiya

    Current Opinion 16 June 2023 Pages: 675 - 680

    

25. Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation

    • Andrea Chiricozzi
    • Michela Ortoncelli
    • Ketty Peris

    Original Research Article Open access 15 June 2023 Pages: 953 - 961

    

26. Apremilast Long-Term Safety Up to 5 Years from 15 Pooled Randomized, Placebo-Controlled Studies of Psoriasis, Psoriatic Arthritis, and Behçet’s Syndrome

    • Philip J. Mease
    • Gülen Hatemi
    • Linda Stein Gold

    Original Research Article Open access 14 June 2023 Pages: 809 - 820

    

27. Global Incidence, Mortality, Risk Factors and Trends of Melanoma: A Systematic Analysis of Registries

    • Junjie Huang
    • Sze Chai Chan
    • Martin C. S. Wong

    Original Research Article 10 June 2023 Pages: 965 - 975

    

28. Dupilumab Provides Clinically Meaningful Responses in Children Aged 6–11 Years with Severe Atopic Dermatitis: Post Hoc Analysis Results from a Phase III Trial

    • Elaine C. Siegfried
    • Michael J. Cork
    • Annie Zhang

    Original Research Article Open access 10 June 2023 Pages: 787 - 798

    

29. Association Between the Use of Topical Calcineurin Inhibitors and the Risk of Cancer Among Patients with Atopic Dermatitis: A Nationwide, Population-Based, Retrospective Cohort Study

    • Hao-Hsin Huang
    • Dereck Shen
    • Chia-Yu Chu

    Original Research Article 06 June 2023 Pages: 799 - 808

    

30. Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis

    • Diana Bernardo
    • Thomas Bieber
    • Tiago Torres

    Review Article Open access 02 June 2023 Pages: 753 - 764

    

31. Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study

    • Tadashi Terui
    • Yukari Okubo
    • Masamoto Murakami

    Original Research Article Open access 26 May 2023 Pages: 837 - 847

    

32. Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial

    • Eric L. Simpson
    • Jonathan I. Silverberg
    • Michael J. Cork

    Original Research Article Open access 22 May 2023 Pages: 609 - 621

    

33. Efficacy and Safety of Nail Psoriasis Targeted Therapies: A Systematic Review

    • Jonathan K. Hwang
    • Jose W. Ricardo
    • Shari R. Lipner

    Systematic Review 20 May 2023 Pages: 695 - 720

    

34. Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials

    • Jonathan I. Silverberg
    • Charles W. Lynde
    • Noah A. Levit

    Publisher Correction Open access 17 May 2023 Pages: 673 - 673

35. Eosinophil–Lymphocyte Ratio, Eosinophil–Neutrophil Ratio, and Eosinophil–Monocyte Ratio in Chronic and Severe Urticaria

    • Sarah Weissmann
    • Nitzan Burrack
    • Amir Horev

    RESEARCH LETTER 17 May 2023 Pages: 669 - 671

36. Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials

    • Linda Stein Gold
    • Diamant Thaçi
    • Marjolein de Bruin-Weller

    Original Research Article Open access 17 May 2023 Pages: 595 - 607

37. Once-Daily Crisaborole Ointment, 2%, as a Long-Term Maintenance Treatment in Patients Aged ≥ 3 Months with Mild-to-Moderate Atopic Dermatitis: A 52-Week Clinical Study

    • Lawrence F. Eichenfield
    • Richard G. Gower
    • John Werth

    Original Research Article Open access 15 May 2023 Pages: 623 - 635

    

38. Automated Facial Acne Lesion Detecting and Counting Algorithm for Acne Severity Evaluation and Its Utility in Assisting Dermatologists

    • Dong Hyo Kim
    • Sukkyu Sun
    • Dae Hun Suh

    Original Research Article 09 May 2023 Pages: 649 - 659

    

39. Acute Generalized Exanthematous Pustulosis: Clinical Features, Differential Diagnosis, and Management

    • Rose Parisi
    • Hemali Shah
    • Roni P. Dodiuk-Gad

    Review Article 08 May 2023 Pages: 557 - 575

    

40. Features and Long-Term Outcomes of Stage IV Melanoma Patients Achieving Complete Response Under Anti-PD-1-Based Immunotherapy

    • Eftychia Chatziioannou
    • Ulrike Leiter
    • Teresa Amaral

    Original Research Article Open access 04 May 2023 Pages: 453 - 467

    

41. Cutaneous Lupus Erythematosus: An Update on Pathogenesis and Future Therapeutic Directions

    • Dennis Niebel
    • Luka de Vos
    • Jörg Wenzel

    Review Article Open access 04 May 2023 Pages: 521 - 540

    

42. Systemic Versus Topical Corticosteroids in the Treatment of DRESS: A Retrospective Cohort Study Followed by a Meta-Analysis

    • Bertrand ShengYang Lian
    • Judy H. Ha
    • Haur Yueh Lee

    Original Research Article 03 May 2023 Pages: 637 - 647

    

43. Differential Diagnosis, Prevention, and Treatment of mpox (Monkeypox): A Review for Dermatologists

    • Aditya K. Gupta
    • Mesbah Talukder
    • Vincent Piguet

    Review Article 27 April 2023 Pages: 541 - 556

    

44. Author’s Reply to Parvathaneni et al. Comment on: “Methotrexate Cutaneous Ulceration: A Systematic Review of Cases”

    • Ronald Berna
    • Meghan Quinlan
    • Emily Baumrin

    Letter to the Editor 17 April 2023 Pages: 491 - 492

45. Comment on: “Methotrexate Cutaneous Ulceration: A Systematic Review of Cases”

    • Aarthi Parvathaneni
    • Adam Olesen
    • Dayna Diven

    Letter to the Editor 17 April 2023 Pages: 487 - 489

    

46. Comment on: “Eyebrow and Eyelash Alopecia: A Clinical Review”

    • Philip R. Cohen

    Letter to the Editor 14 April 2023 Pages: 485 - 486

47. Chronic Telogen Effluvium: Is it a Distinct Condition? A Systematic Review

    • Adam Daunton
    • Matthew Harries
    • Andrew Messenger

    Systematic Review 13 April 2023 Pages: 513 - 520

    

48. Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis

    • Chia-Ling Yu
    • Po-Yi Chou
    • Ching-Chi Chi

    Systematic Review 03 April 2023 Pages: 721 - 730

    

49. Blue Nail Discoloration: Literature Review and Diagnostic Algorithms

    • Jonathan K. Hwang
    • Shari R. Lipner

    Review Article 27 March 2023 Pages: 419 - 441

    

50. Correction to: Ruxolitinib Cream 1.5%: A Review in Mild to Moderate Atopic Dermatitis

    • Sheridan M. Hoy

    Correction Open access 24 March 2023 Pages: 495 - 495